AVTXVSCNTX• 28 Days (Normalized)
AVTX vs CNTX (Avalo Therapeutics Inc. vs Context Therapeutics Inc.)
Showing Closing Date Range from Aug, 21 to Sep, 18, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
AVTX Performance $16.57
-16.44%
Avalo Therapeutics Inc.
Normalized Baseline0.00%
CNTX Performance $0.37
-26.38%
Context Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin AVTX LEADS
+9.94%
AVTX outperforming by 9.94%
AVTXCNTX
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
AVTX CNTX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | AVTX Price | AVTX Gain (%) | CNTX Price | CNTX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 18, 2026 | $16.57 | -16.44% | $0.37 | -26.38% | +9.94% |
| Sep 17, 2026 | $16.69 | -15.83% | $0.38 | -23.40% | +7.57% |
| Sep 16, 2026 | $16.58 | -16.39% | $0.38 | -24.20% | +7.81% |
| Sep 15, 2026 | $16.07 | -18.96% | $0.36 | -27.20% | +8.24% |
| Sep 14, 2026 | $16.18 | -18.41% | $0.35 | -29.80% | +11.39% |
| Sep 11, 2026 | $16.12 | -18.71% | $0.35 | -30.00% | +11.29% |
| Sep 10, 2026 | $17.18 | -13.36% | $0.37 | -26.80% | +13.44% |
| Sep 09, 2026 | $18.21 | -8.17% | $0.37 | -26.00% | +17.83% |
| Sep 08, 2026 | $19.71 | -0.61% | $0.38 | -24.80% | +24.19% |
| Sep 04, 2026 | $19.23 | -3.03% | $0.36 | -27.60% | +24.57% |
| Sep 03, 2026 | $19.00 | -4.19% | $0.36 | -27.40% | +23.21% |
| Sep 02, 2026 | $19.34 | -2.47% | $0.36 | -27.40% | +24.93% |
| Sep 01, 2026 | $18.95 | -4.44% | $0.36 | -27.20% | +22.76% |
| Aug 31, 2026 | $19.34 | -2.47% | $0.39 | -22.00% | +19.53% |
| Aug 28, 2026 | $19.59 | -1.21% | $0.38 | -23.20% | +21.99% |
Page 1 of 2